Frances R. Levin, MD

Board Certifications: 
Psychiatry, Addiction Psychiatry
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Addiction Psychiatry, Addictive Disorders, Adult ADHD, Clinical Research, Substance Use

Academic Appointments

  • Kennedy-Leavy Professor of Psychiatry in the Division of Substance Abuse at CUMC

Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Clinical Psychiatry at Columbia University and Chief of the Division on Substance Use, and Director of the Addiction Psychiatry Fellowship Program at New York Presbyterian Hospital. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic.

She is the principal investigator on several federally funded grants, including a Medication Development Center, a T32 NIDA funded Substance Use Research Fellowship, a K24 Mid Career Investigator Award and collaborates on several other grants. Her research interests include pharmacologic and psychotherapeutic treatment interventions for cocaine and marijuana abuse, and treatment approaches for substance abusers with attention-deficit hyperactivity disorder and other psychiatric illnesses.

Dr. Levin has over 200 articles and book chapters and serves on several advisory panels. She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry and currently serves as the Chair of the APA council on addiction psychiatry. Please click here to listen to both my BlogTalk Radio Show: http://www.blogtalkradio.com/columbiapsychiatrynyspi/2013/12/10/cracking...

Pills and Needles: Agonizing over Antagonists http://www.blogtalkradio.com/columbiapsychiatrynyspi/2013/12/12/pills-an...

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Location(s)

CUMC/Herbert Pardes Building of the New York State Psychiatric Institute
1051 Riverside Drive
New York, NY 10032
Primary

Insurance Accepted

Medicare

  • Medicare

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Weill Cornell Medical College
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Board Certifications

  • Psychiatry
  • Addiction Psychiatry

Honors & Awards

Dr. Levin is the recipient of the 2015 Founder's Award from the American Academy of Addiction Psychiatry and is an American Psychiatric Association Distinguished Fellow. She is a Best Doctor, New York Magazine in Addiction Psychiatry since 2011.

America's Top Doctor
NY Top Doctor

Research

Research Interests

  • Substance Use Disorders
    Psychiatric Comorbidity
    Adult ADHD

Grants

RESEARCH FELLOWSHIP IN SUBSTANCE ABUSE DISORDER (Federal Gov)

Jul 1 2018 - Jun 30 2023

DOES MEDICAL CANNABIS REDUCE OPIOID ANALGESICS IN HIV+ AND HIV ADULTS WITH PAIN? (Federal Gov)

Jul 1 2017 - Jun 30 2022

PROVIDERS CLINICAL SUPPORT SYSTEM FOR MEDICATION ASSISTED TREATMENT (PCSS-MAT) - TRAINING AND IMPLEMENTATION (Federal Gov)

Aug 1 2016 - Jul 31 2019

A SEQUENCED BEHAVIORAL AND MEDICATION INTERVENTION FOR COCAINE DEPENDENCE (Federal Gov)

Jun 1 2014 - May 31 2019

A SEQUENCED BEHAVIORAL AND MEDICATION INTERVENTION FOR COCAINE DEPENDENCE (Federal Gov)

Jun 1 2014 - May 31 2018

A SEQUENCED BEHAVIORAL AND MEDICATION INTERVENTION FOR COCAINE DEPENDENCE (Federal Gov)

Jun 1 2014 - May 31 2018

PROVIDERS CLINICAL SUPPORT SYSTEM FOR OPIOID THERAPIES (Federal Gov)

Sep 30 2014 - Sep 29 2017

APA SAMHSA SUBSTANCE ABUSE MINORITY FELLOWSHIP (Private)

Jul 1 2016 - Jun 30 2017

SHARED PHARMACOTHERAPEUTIC STRATEGIES FOR CANNABINOID & OPIOID USE DISORDERS (Federal Gov)

Sep 1 2014 - Jun 30 2017

QUETIAPINE TREATMENT FOR CANNABIS DEPENDENCE (Federal Gov)

Aug 1 2012 - Aug 31 2016

IMPLEMENTING PHARMACOTHERAPIES FOR OPIOD DEPENDENCE: COLLABORATIVE STRATEGIES FOR TRAINING HEALTH PROFESSIONALS (Federal Gov)

Aug 1 2013 - Jul 31 2016

TRANSLATIONAL RESEARCH TRANINIG ON ADDICTION FOR RACIAL/ ETHNIC MINORITIES (Federal Gov)

Jun 15 2013 - Feb 28 2015

MULTI-SITE CONTROLLED TRIAL OF COCAINE VACCINE (6 OF 6) COLUMBIA UNIVERSITY SITE (Federal Gov)

Sep 15 2008 - Jul 31 2013

HUMAN COCAINE VACCINE (TA-CD) IN THE TREATMENT OF COCAINE DEPENDENCE (Federal Gov)

Oct 1 2010 - Sep 30 2012

Selected Publications

  • Nunes EV, Levin FR: Treatment of depression in patients with alcohol or drug dependence: A meta-analysis. JAMA 2004;291(15): 1887-1896
  • Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV: Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence 2011;116(1-3): 142-150
  • Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR: Extended-release mixed amphetamine sales and topiramate for cocaine dependence: A randomized controlled trial.. Biological Psychiatry 2012;72(11): 950-956
  • Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, Bisaga A, Sullivan MA, Carpenter KM: A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addictive Behaviors 2013;108(6): 1084-1094
  • Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J : Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2015;72(6): 593-602